DISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS Marc A Schuckit I - - PDF document

disclosures management of opioid use disorders
SMART_READER_LITE
LIVE PREVIEW

DISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS Marc A Schuckit I - - PDF document

DISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS Marc A Schuckit I have nothing to declare Distinguished Professor of Psychiatry, UCSD Medical School LECTURE COVERS SUDs ARE IMPORTANT Drug groups & problems Affect > 20% of your


slide-1
SLIDE 1

1

MANAGEMENT OF OPIOID USE DISORDERS

Marc A Schuckit Distinguished Professor of Psychiatry, UCSD Medical School

DISCLOSURES

I have nothing to declare

SUDs ARE IMPORTANT

Affect > 20% of your patients Are identified by non-experts Alcohol and drug use ↓ Rx responses Mimick most psychiatric Dx Deadly: opioid 33k ODs/yr Opoids cost US > $75 billion/yr Drug groups & problems Substance use disorders Criteria Course Treatment Identification/intervention Detoxification Rehabilitation After you’re gone

LECTURE COVERS

slide-2
SLIDE 2

2

Drug groups & problems Substance use disorders Criteria Course Treatment Identification/intervention Detoxification Rehabilitation After you’re gone

LECTURE COVERS DRUG GROUPS

Based on: Usual effects At usual doses Group then predicts: Pattern of problems

DRUG GROUPS

Depressants Stimulants

Opioids

Cannabinols Hallucinogens PCP Solvents Others

THE GOOD, BAD, & UGLY

Good ↓ pain, cough, shock, diarrhea ↑ euphoria, tranquility, sedation Bad Tolerance, craving, ↓ respirations Ugly: If opioid use disorder Is VERY hard to stop using

slide-3
SLIDE 3

3

DRUG PROBLEMS

Overdose Withdrawal

Delirium Psychosis Major depression Anxiety

Drug groups & problems Substance use disorders Criteria Course Treatment Identification/intervention Detoxification Rehabilitation After you’re gone

LECTURE COVERS SUBSTANCE USE DISORDER

In same year 2+ of: Failed roles Hazardous use Social problems Tolerance* Withdrawal* Use longer/more Unable to ↓ Lots time use ↓ activities Use despite probs Craving

* Special re opioids

Fluctuating:

  • Controlled use
  • Problems
  • Abstinence

>20% spontaneous remission In richer & poorer Prevention: NEVER USE FOR A HIGH

SUD COURSE

slide-4
SLIDE 4

4

Drug groups & problems Substance use disorders Criteria Course Treatment Identification/intervention Detoxification Rehabilitation After you’re gone

LECTURE COVERS OVERDOSE

Symptoms Awake respirations <12/min*/stupor*/miosis* Also: ↓ temp/↓ gut sounds/pulmonary edema Treatment Ventilate Naloxone: 0.04mg IM, IN, IV— but not oral If no ↑ respiration in 2 min →0.5mg → 2mg → 5mg → 10mg → 15mg

Opioid OD Decisions

Resp < 12min when awake YES Long Acting Opioid? Yes NO Awake/alert NO Yes NO

|

Long Acting Opioid? NO Yes Observe 8+hr Observe 6hr

~ p last naloxone

O2 Naloxone Continuous IV Naloxone ± Intubate Observe 6hr

~ p IV stop

ICU ICU Refer for OP Rx

Boyer NEJM 2012

STAGES OF RX

Identification/intervention: drop stereotypes Detoxification Physical exam & history Rehabilitation Enhance motivation Help readjust to life Aftercare Reassurance Medications Relapse prevention Medications

slide-5
SLIDE 5

5

Relationships School or job Accidents TO ID: ASK ABOUT PROBLEMS

Then tie in substances

Legal Health

QUESTIONNAIRES

CAGE-AID (2+): Feel need cut down Feel bad or guilty Annoyed by criticisms Eye-opener for relief/steady Drug Use Questionnaire (DAST-10: 3+) Non-med use/multi drugs/not stop/blackout/guilt/ Complaints/neglect/illegal/withdrawal/med probs

MOTIVATIONAL INTERVIEWING

Build trust Empathic Avoid ↑ resistance Patient is in charge Elicit motivational statements Explore ambivalence Monitor readiness to change

STAGES OF RX

Identification/intervention Detoxification Physical exam & history Vitamins Rehabilitation Enhance motivation Help readjust to life Aftercare Reassurance Medications Relapse prevention Medications

slide-6
SLIDE 6

6

DETOX

Depressants

Opioids

Stimulants (no specific Rx)

DETOX RX

Physical exam Rest & education Nutrition Meds for:

Opioids

KEY MEDICATIONS

Methadone (oral): Mu-opioid agonist; ½ life 15-20 hrs Buprenorphine (SL or buccal) Partial mu agonist; kappa antagonist ½ life 3 hrs (longer recepter occupation) Mu antagonists: Naltrexone ½ life: oral 4-13 hrs IM 5-10 days Naloxone (not oral): onset 2 min; action 20-90 min

OPIOID WITHDRAWAL

Symptoms opposite of acute effects Timing depends on drug length action PE, educate, motivate Methadone or Buprenorphene

slide-7
SLIDE 7

7

CLINICAL OPIOID WITHDRAWAL SCALE (COWS)

Pulse > 80 Rhinorrhea Sweating Cramps/naus/vomit Restless Tremor Pupils ↑ Yawning Bone/joint pain Anxous/irritable Goosebumps Each scored 1-4 or 1-5 Total: 5-12 = mild 25-36 = mod/severe 13-24 = mod > 36 = severe

WITHDRAWAL

Detox ≠ rehabilitation Onset symptoms Naloxone: in 2 minutes Short acting (heroin): ~ 8 hrs, ↓ day 4 Long acting (methadone): 1+ days, ↓ day 10 Protracted withdrawal: 2 weeks to 2+ months Fatigue ↓ appetite insomnia anhedonia

LONG ACTING OPIOID TAPER

Oral methadone SL buprenorphine PE PE: Rx at mild sympt Initial dose (ck in 1 hr; adjust) 10 mg < current dose 4-8 mg 10-30 mg/d (÷) Stabilize 7-14 days 2-5 days Taper ~ 0-20% of initial dose Every 1-2 days

OPIOID-FREE DETOX

Med Dose Target

Clonidine 0.1-0.2mg q 4h Flu-like patch 1 for 100-200 # Diazepam 2-10mg q 4h Insom/anxiety Imodium 4mg, then 2mg Diarrhea Naproxin 500mg 2x/d Aches/pain Compazine 5-10mg q 4h Naus/vomit

slide-8
SLIDE 8

8

STAGES OF RX

Identification/intervention Detoxification Physical exam & history Vitamins Rehabilitation Enhance motivation Help readjust to life Aftercare Reassurance Medications Relapse prevention Medications

REHABILITATION

Increase motivation Help rebuild life Relapse prevention +/- medications

REHAB: NALTREXONE

Action: Blocks opioid high/↓ craving Restriction: Must be opioid free Induction: Test : 12.5mg; in 4 h 25-50mg Day 1: Begin 50-100mg/d Maintenance: 100mg Mon & Wed 150mg Fri OR 380mg IM/mo

MAINTENANCE GOALS

Substitute safer opioid Oral to avoid craving set on by needles Long acting to avoid daytime symptoms Use 1+ years— note OD danger when stop Rx includes counseling pain control monitoring Goals: ↓ IV dangers ↑ Health Crime Work OD Relationships

slide-9
SLIDE 9

9

REHAB:METHADONE

Action: Oral & long ½ life opioid Restriction: Only in special clinics Induction: 1-2 wk:15-30mg ↑ 10-50mg ~q 5d to 50-100mg Maintenance: Consider take-home weekend dose if adherent to Rx at 8 wk

REHAB: BUPRINORPHINE

Action: SL/buccal long ½ life opioid & naloxone (4 to 1 ratio) Restriction: Trained pvt doc office OK Induction: Wk 1-8: 4-8mg/d up to 16-32mg Maintenance: Dose on SE and craving

CBT ↓dysfunctional thoughts (must have drugs)

↑ rational thoughts (I can change) Relapse prevention (risk never ends) Anticipate triggers Learn to cope w/triggers Change behaviors (sober friends; ↓ stress)